Cannovum Cannabis AG Logo

Cannovum Cannabis AG

Licensed importer, wholesaler, and manufacturer of medical cannabis products.

27N0 | DU

Overview

Corporate Details

ISIN(s):
DE000A30VHF2 (+2 more)
LEI:
894500IT61F9P85YMM31
Country:
Germany
Address:
Stresemannstraße 23, 10963 Berlin

Description

Cannovum Cannabis AG is a pharmaceutical company that operates as a licensed importer, wholesaler, and manufacturer of high-quality medical cannabis products. The company's primary focus is on supplying the medical market and providing patients with therapeutic options. In response to evolving regulations, Cannovum is also strategically positioning itself for the legalized recreational cannabis market. This includes initiatives aimed at public education and brand awareness, alongside developing a product portfolio for the adult-use consumer segment. The company is also engaged in expanding its operations into other European markets.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2022-09-07 08:30
Cannovum AG: Record sales and new customers in the first half of 2022
English HTML 6.7 KB
2022-07-04 09:04
Cannovum AG part of the International Expert Hearings on Cannabis Legalization
English HTML 7.6 KB
2022-04-27 09:45
Cannovum AG resolves capital increase from authorized capital excluding subscri…
English HTML 7.0 KB
2022-02-09 08:41
Cannovum AG launches Cannabis Medical Education Platform
English HTML 7.7 KB
2022-01-06 08:40
Cannovum AG now offers Next Day Delivery for med. cannabis
English HTML 5.9 KB
2021-11-25 13:20
Cannovum AG decides to enter the recreational cannabis market
English HTML 6.4 KB
2021-09-28 09:00
Cannovum AG expands cannabis wholesale license and enters the active ingredient…
English HTML 5.6 KB
2021-09-08 13:44
Cannovum AG expands Supervisory Board and Medical Advisory Board
English HTML 6.3 KB
2021-09-06 08:33
Cannovum AG starts European cannabis expansion with founding of Cannovum Iberia…
English HTML 6.3 KB
2021-06-29 08:28
Cannovum AG enters the full-spectrum cannabis extract market
English HTML 6.6 KB
2021-06-24 09:06
Cannovum AG enters supply agreement for medical cannabis with Aurora Europe
English HTML 6.4 KB
2021-06-15 10:02
Cannovum AG enters cannabis market segment Dronabinol
English HTML 6.4 KB
2021-05-06 09:24
Cannovum AG startet mit Direct Listing an der Borse Dusseldorf
German HTML 6.5 KB

Automate Your Workflow. Get a real-time feed of all Cannovum Cannabis AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cannovum Cannabis AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cannovum Cannabis AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.